Supreme Court Ruling on Generic Drug Labeling

The Supreme Court has ruled in favor of Hikma Pharmaceutical, upholding its right to use a ‘skinny label’ without infringing Amarin’s patents. The decision could have significant implications for future legal battles over drug labeling.